CIITA and neoplasm: Thus, either CIITA-tumors do not need necessarily accessory molecules to perform their APC function in vivo, or other accessory molecules are involved to provide the second signal, or tumor-specific, and possibly organ-specific constraints limit the immune stimulating function of CIITA-driven MHC class II expressing tumor cells.